
Upgrades
Guggenheim upgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Sell to Neutral. Teladoc Health earned $0.44 in the second quarter, compared to $0.86 in the year-ago quarter. The stock has a 52-week-high of $95.71 and a 52-week-low of $23.08. At the end of the last trading period, Teladoc Health closed at $24.03.